TABLE 2.

Renin–angiotensin–aldosterone system inhibitors and risk of non‐SARS‐CoV‐2 related all‐cause mortality

Non‐SARS‐CoV‐2 related all‐cause mortality	OR (95% CI)	P value
ACE inhibitors (9, n = 35 727) *	0.73 (0.59, 0.90)	.004
Cohort studies (5)	0.71 (0.57, 0.88)	.002
Randomized controlled trial (4)	0.83 (0.31, 2.17)	.697
Adjusted risk factors ORs studies (5)	0.73 (0.59, 0.90)	.002
ARB (1, n = 22 996)	0.47 (0.30, 0.72)	‐
Cohort studies (1)	0.47 (0.30, 0.72)	Not given

^* number of studies and population. OR = odds ratio; 95% CI = 95% confidence interval; ACE = angiotensin converting enzyme; ARB = angiotensin receptor blocker.